Nicholas Lawrence

6PUBLICATIONS
38CO-AUTHORS
Molecular targetsCharacterisation of biological macromoleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 23, 2026
Unc-51 like kinase 3 (ULK3) contributes to autophagy and cell survival in multiple myeloma.

|Aug 20, 2025
Unc-51 Like Kinase 3 (ULK3) is essential for autophagy and cell survival in multiple myeloma.

Marilena Tauro, Tao Li, Praneeth R Sudalagunta

|Jul 10, 2024
Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function.

Shengyan Xiang, Kendall C Craig, Xingju Luo

|Jun 15, 2022
Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting.

Mithila Sawant, Kiran Mahajan, Arun Renganathan

|Mar 23, 2021
Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results.

Joseph Pidala, Kelly Walton, Hany Elmariah

|Feb 02, 2021
Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer.

Jeremy J McGuire, Jeremy S Frieling, Chen Hao Lo

Pageof 1

Frequent Collaborators

3 joint publications

Conor Lynch

3 joint publications

Harshani R Lawrence

2 joint publications

Timothy Tran

2 joint publications

John L Cleveland